Effect of NOS inhibition on rat gastric matrix metalloproteinase production during endotoxemia

Emily K. Robinson, Christine M. Seaworth, James W. Suliburk, Sasha D. Adams, Lillian S. Kao, David W. Mercer

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Matrix metalloproteinases (MMPs) degrade the extracellular matrix and contribute to LPS-induced gastric injury. MMPs are closely modulated by their activators, membrane type-MMP (MT-MMPs) and their endogenous inhibitors, the tissue inhibitors of metalloproteinases (TIMPs). As LPS-induced gastric injury is mediated in part by iNOS, and NO modulates MMP production in vitro, we hypothesized that NOS inhibition would similarly modulate LPS-induced gastric MMP production. Therefore, the purpose of these studies was to compare the effects of selective and nonselective NOS inhibition on LPS-induced gastric MMP production. Methods - Sprague-Dawley rats were given either the nonselective NOS inhibitor NG-nitro-L-arginine methyl ester (L-NAME; 5 mg/kg, s.c.), a selective iNOS inhibitor, aminoguanidine (45 mg/kg, i.p.) or L-N-iminoethyl-lysine (L-NIL; 10 mg/kg, i.p.), or vehicle 15 min before saline or LPS (20 mg/kg, i.p.) and killed 24 h after LPS administration. Stomachs were assessed for macroscopic injury (computed planimetry), and gastric mucosal MMP production was assessed by gelatin zymography, in situ zymography, and Western analysis for MMP-2, MT1-MMP, and TIMP-2. (n ≥ 4/group; ANOVA). Results - Aminoguanidine treatment decreased LPS-induced macroscopic gastric injury as well as MMP-2 and MT1-MMP protein production while having no effect on TIMP-2 protein levels. L-NIL similarly attenuated the induction of MMP-2 and MT1-MMP by LPS. L-NAME failed to attenuate LPS induced gastric injury or MT1-MMP protein induction and increased MMP-2 levels. L-NAME similarly had no effect on gastric TIMP-2 production. Conclusions - Selective iNOS inhibition decreases gastric MMP-2 activity after LPS administration, whereas nonselective inhibition increases MMP-2 levels. The ability of selective iNOS inhibition to ameliorate LPS-induced gastric injury may be due in part to its inhibition of active MMP-2 production, whereas nonselective NOS inhibitors increase MMP-2 levels and maintain gastric injury after LPS administration.

Original languageEnglish (US)
Pages (from-to)507-514
Number of pages8
JournalShock
Volume25
Issue number5
DOIs
StatePublished - May 1 2006

Fingerprint

Endotoxemia
Matrix Metalloproteinases
Stomach
Matrix Metalloproteinase 2
Matrix Metalloproteinase 14
NG-Nitroarginine Methyl Ester
Tissue Inhibitor of Metalloproteinase-2
Wounds and Injuries
Membrane-Associated Matrix Metalloproteinases
Tissue Inhibitor of Metalloproteinases
Proteins
Matrix Metalloproteinase Inhibitors
Gelatin
Extracellular Matrix
Sprague Dawley Rats
Analysis of Variance

Keywords

  • Aminoguanadine
  • Gelatinase
  • Injury
  • Lipopolysaccharide
  • MT1-MMP
  • N -nitro-L-arginine methyl ester
  • NO
  • TIMP

ASJC Scopus subject areas

  • Emergency Medicine
  • Critical Care and Intensive Care Medicine

Cite this

Effect of NOS inhibition on rat gastric matrix metalloproteinase production during endotoxemia. / Robinson, Emily K.; Seaworth, Christine M.; Suliburk, James W.; Adams, Sasha D.; Kao, Lillian S.; Mercer, David W.

In: Shock, Vol. 25, No. 5, 01.05.2006, p. 507-514.

Research output: Contribution to journalArticle

Robinson, Emily K. ; Seaworth, Christine M. ; Suliburk, James W. ; Adams, Sasha D. ; Kao, Lillian S. ; Mercer, David W. / Effect of NOS inhibition on rat gastric matrix metalloproteinase production during endotoxemia. In: Shock. 2006 ; Vol. 25, No. 5. pp. 507-514.
@article{90715963161b4e99b0661b3796ae64cb,
title = "Effect of NOS inhibition on rat gastric matrix metalloproteinase production during endotoxemia",
abstract = "Matrix metalloproteinases (MMPs) degrade the extracellular matrix and contribute to LPS-induced gastric injury. MMPs are closely modulated by their activators, membrane type-MMP (MT-MMPs) and their endogenous inhibitors, the tissue inhibitors of metalloproteinases (TIMPs). As LPS-induced gastric injury is mediated in part by iNOS, and NO modulates MMP production in vitro, we hypothesized that NOS inhibition would similarly modulate LPS-induced gastric MMP production. Therefore, the purpose of these studies was to compare the effects of selective and nonselective NOS inhibition on LPS-induced gastric MMP production. Methods - Sprague-Dawley rats were given either the nonselective NOS inhibitor NG-nitro-L-arginine methyl ester (L-NAME; 5 mg/kg, s.c.), a selective iNOS inhibitor, aminoguanidine (45 mg/kg, i.p.) or L-N-iminoethyl-lysine (L-NIL; 10 mg/kg, i.p.), or vehicle 15 min before saline or LPS (20 mg/kg, i.p.) and killed 24 h after LPS administration. Stomachs were assessed for macroscopic injury (computed planimetry), and gastric mucosal MMP production was assessed by gelatin zymography, in situ zymography, and Western analysis for MMP-2, MT1-MMP, and TIMP-2. (n ≥ 4/group; ANOVA). Results - Aminoguanidine treatment decreased LPS-induced macroscopic gastric injury as well as MMP-2 and MT1-MMP protein production while having no effect on TIMP-2 protein levels. L-NIL similarly attenuated the induction of MMP-2 and MT1-MMP by LPS. L-NAME failed to attenuate LPS induced gastric injury or MT1-MMP protein induction and increased MMP-2 levels. L-NAME similarly had no effect on gastric TIMP-2 production. Conclusions - Selective iNOS inhibition decreases gastric MMP-2 activity after LPS administration, whereas nonselective inhibition increases MMP-2 levels. The ability of selective iNOS inhibition to ameliorate LPS-induced gastric injury may be due in part to its inhibition of active MMP-2 production, whereas nonselective NOS inhibitors increase MMP-2 levels and maintain gastric injury after LPS administration.",
keywords = "Aminoguanadine, Gelatinase, Injury, Lipopolysaccharide, MT1-MMP, N -nitro-L-arginine methyl ester, NO, TIMP",
author = "Robinson, {Emily K.} and Seaworth, {Christine M.} and Suliburk, {James W.} and Adams, {Sasha D.} and Kao, {Lillian S.} and Mercer, {David W.}",
year = "2006",
month = "5",
day = "1",
doi = "10.1097/01.shk.0000209543.83929.bd",
language = "English (US)",
volume = "25",
pages = "507--514",
journal = "Shock (Augusta, Ga.)",
issn = "1073-2322",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Effect of NOS inhibition on rat gastric matrix metalloproteinase production during endotoxemia

AU - Robinson, Emily K.

AU - Seaworth, Christine M.

AU - Suliburk, James W.

AU - Adams, Sasha D.

AU - Kao, Lillian S.

AU - Mercer, David W.

PY - 2006/5/1

Y1 - 2006/5/1

N2 - Matrix metalloproteinases (MMPs) degrade the extracellular matrix and contribute to LPS-induced gastric injury. MMPs are closely modulated by their activators, membrane type-MMP (MT-MMPs) and their endogenous inhibitors, the tissue inhibitors of metalloproteinases (TIMPs). As LPS-induced gastric injury is mediated in part by iNOS, and NO modulates MMP production in vitro, we hypothesized that NOS inhibition would similarly modulate LPS-induced gastric MMP production. Therefore, the purpose of these studies was to compare the effects of selective and nonselective NOS inhibition on LPS-induced gastric MMP production. Methods - Sprague-Dawley rats were given either the nonselective NOS inhibitor NG-nitro-L-arginine methyl ester (L-NAME; 5 mg/kg, s.c.), a selective iNOS inhibitor, aminoguanidine (45 mg/kg, i.p.) or L-N-iminoethyl-lysine (L-NIL; 10 mg/kg, i.p.), or vehicle 15 min before saline or LPS (20 mg/kg, i.p.) and killed 24 h after LPS administration. Stomachs were assessed for macroscopic injury (computed planimetry), and gastric mucosal MMP production was assessed by gelatin zymography, in situ zymography, and Western analysis for MMP-2, MT1-MMP, and TIMP-2. (n ≥ 4/group; ANOVA). Results - Aminoguanidine treatment decreased LPS-induced macroscopic gastric injury as well as MMP-2 and MT1-MMP protein production while having no effect on TIMP-2 protein levels. L-NIL similarly attenuated the induction of MMP-2 and MT1-MMP by LPS. L-NAME failed to attenuate LPS induced gastric injury or MT1-MMP protein induction and increased MMP-2 levels. L-NAME similarly had no effect on gastric TIMP-2 production. Conclusions - Selective iNOS inhibition decreases gastric MMP-2 activity after LPS administration, whereas nonselective inhibition increases MMP-2 levels. The ability of selective iNOS inhibition to ameliorate LPS-induced gastric injury may be due in part to its inhibition of active MMP-2 production, whereas nonselective NOS inhibitors increase MMP-2 levels and maintain gastric injury after LPS administration.

AB - Matrix metalloproteinases (MMPs) degrade the extracellular matrix and contribute to LPS-induced gastric injury. MMPs are closely modulated by their activators, membrane type-MMP (MT-MMPs) and their endogenous inhibitors, the tissue inhibitors of metalloproteinases (TIMPs). As LPS-induced gastric injury is mediated in part by iNOS, and NO modulates MMP production in vitro, we hypothesized that NOS inhibition would similarly modulate LPS-induced gastric MMP production. Therefore, the purpose of these studies was to compare the effects of selective and nonselective NOS inhibition on LPS-induced gastric MMP production. Methods - Sprague-Dawley rats were given either the nonselective NOS inhibitor NG-nitro-L-arginine methyl ester (L-NAME; 5 mg/kg, s.c.), a selective iNOS inhibitor, aminoguanidine (45 mg/kg, i.p.) or L-N-iminoethyl-lysine (L-NIL; 10 mg/kg, i.p.), or vehicle 15 min before saline or LPS (20 mg/kg, i.p.) and killed 24 h after LPS administration. Stomachs were assessed for macroscopic injury (computed planimetry), and gastric mucosal MMP production was assessed by gelatin zymography, in situ zymography, and Western analysis for MMP-2, MT1-MMP, and TIMP-2. (n ≥ 4/group; ANOVA). Results - Aminoguanidine treatment decreased LPS-induced macroscopic gastric injury as well as MMP-2 and MT1-MMP protein production while having no effect on TIMP-2 protein levels. L-NIL similarly attenuated the induction of MMP-2 and MT1-MMP by LPS. L-NAME failed to attenuate LPS induced gastric injury or MT1-MMP protein induction and increased MMP-2 levels. L-NAME similarly had no effect on gastric TIMP-2 production. Conclusions - Selective iNOS inhibition decreases gastric MMP-2 activity after LPS administration, whereas nonselective inhibition increases MMP-2 levels. The ability of selective iNOS inhibition to ameliorate LPS-induced gastric injury may be due in part to its inhibition of active MMP-2 production, whereas nonselective NOS inhibitors increase MMP-2 levels and maintain gastric injury after LPS administration.

KW - Aminoguanadine

KW - Gelatinase

KW - Injury

KW - Lipopolysaccharide

KW - MT1-MMP

KW - N -nitro-L-arginine methyl ester

KW - NO

KW - TIMP

UR - http://www.scopus.com/inward/record.url?scp=33646819044&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646819044&partnerID=8YFLogxK

U2 - 10.1097/01.shk.0000209543.83929.bd

DO - 10.1097/01.shk.0000209543.83929.bd

M3 - Article

C2 - 16680016

AN - SCOPUS:33646819044

VL - 25

SP - 507

EP - 514

JO - Shock (Augusta, Ga.)

JF - Shock (Augusta, Ga.)

SN - 1073-2322

IS - 5

ER -